In the US, Degarelix (degarelix systemic) is a member of the following drug classes: gonadotropin-releasing hormone antagonists, hormones/antineoplastics and is used to treat Prostate Cancer.
US matches:
- Degarelix
- Degarelix Acetate
- Degarelix Subcutaneous
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L02BX02
CAS registry number (Chemical Abstracts Service)
0214766-78-6
Chemical Formula
C82-H103-Cl-N18-O16
Molecular Weight
1632
Therapeutic Categories
Antineoplastic agent
Gonadotropin releasing hormone (GnRH) receptor antagonist
Chemical Names
D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyrimidinyl]carbonyl]amino]-L-phenylalanyl-4-[(aminocarbonyl)amino]-D-phenylalanyl-L-leucyl-N⁶-(1-methylethyl)-L-l (USAN)
N-acetyl-3-(naphtalen-2-yl)-D-alanyl-4-chloro-D-phenylalanyl-3-(pyridin-3-yl)-D-alanyl-L-seryl-4-[[[(4S)-2,6-dioxohexahydroprymidin-4-yl]carbonyl]amino]-L-phenylalanyl-4-(carbamoylamino)-D-phenylalanyl-L-leucyl-N⁶-(1-methylethyl)-L-lysyl-L-prolyl-D-alanin (WHO)
Foreign Names
- Degarelixum (Latin)
- Degarelix (German)
- Dégarélix (French)
- Degarelix (Spanish)
Generic Names
- Degarelix (OS: USAN)
- Degarelix Acetate (OS: USAN)
- ASP-3550 (IS)
- FE200486 (IS)
Brand Names
- Firmagon
Ferring, Greece
- Degarelix for Injection
Ferring, United States
- Firmagon
Ferring, Austria; Ferring, Switzerland; Ferring, Germany; Ferring, France; Ferring, United Kingdom; Ferring, United States
- FIRMAGON
Ferring, Sweden
International Drug Name Search
Glossary
IS | Inofficial Synonym |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
WHO | World Health Organization |
Click for further information on drug naming conventions and
International Nonproprietary Names.